Monoclonal antibodies
CORPORATE INNOVATION AS AN ENGINE FOR CHANGE: Molecular Diagnostics David Okrongly, Ph.D. SVP Molecular Diagnostics Siemens Healthcare.
Fortunato Ciardiello Division of Medical Oncology, Department of Clinical and Experimental Medicine, Second University of Naples, Italy.
